Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy K Lu

Showing results (11-20 of 154) with videos related to

Pageof 16
Sort By:
ACS Synthetic Biology|November 22, 2019
Advancing CRISPR-Based Programmable Platforms beyond Genome Editing in Mammalian CellsYasutomi Higashikuni, Timothy K Lu
Mbio|October 12, 2017
An Engineered Synthetic Pathway for Discovering Nonnatural Nonribosomal Peptides in <i>Escherichia coli</i>Sara Cleto, Timothy K Lu
Proceedings of the National Academy of Sciences of the United States of America|March 4, 2009
Engineered bacteriophage targeting gene networks as adjuvants for antibiotic therapyTimothy K Lu, James J Collins
Antibiotics (Basel, Switzerland)|January 17, 2020
Development and Challenges of Antimicrobial Peptides for Therapeutic ApplicationsCharles H Chen, Timothy K Lu
Annual Review of Biomedical Engineering|May 15, 2012
Synthetic biology: an emerging engineering disciplineAllen A Cheng, Timothy K Lu
Current Opinion in Microbiology|August 27, 2011
The next generation of bacteriophage therapyTimothy K Lu, Michael S Koeris
Proceedings of the National Academy of Sciences of the United States of America|June 27, 2007
Dispersing biofilms with engineered enzymatic bacteriophageTimothy K Lu, James J Collins
Annual Review of Microbiology|July 15, 2020
Microbes as BiosensorsMaria Eugenia Inda, Timothy K Lu
Current Opinion in Chemical Biology|June 27, 2022
Engineering the human gut commensal Bacteroides thetaiotaomicron with synthetic biologyYong Lai, Naoki Hayashi, Timothy K Lu
ACS Synthetic Biology|March 22, 2022
Sense-and-Respond Payload Delivery Using a Novel Antigen-Inducible Promoter Improves Suboptimal CAR-T ActivationTingxi Guo, Dacheng Ma, Timothy K Lu
Pageof 16

Showing results (11-20 of 154) with videos related to

Sort By:
Pageof 16
ACS Synthetic Biology|November 22, 2019
Advancing CRISPR-Based Programmable Platforms beyond Genome Editing in Mammalian CellsYasutomi Higashikuni, Timothy K Lu
Mbio|October 12, 2017
An Engineered Synthetic Pathway for Discovering Nonnatural Nonribosomal Peptides in <i>Escherichia coli</i>Sara Cleto, Timothy K Lu
Proceedings of the National Academy of Sciences of the United States of America|March 4, 2009
Engineered bacteriophage targeting gene networks as adjuvants for antibiotic therapyTimothy K Lu, James J Collins
Antibiotics (Basel, Switzerland)|January 17, 2020
Development and Challenges of Antimicrobial Peptides for Therapeutic ApplicationsCharles H Chen, Timothy K Lu
Annual Review of Biomedical Engineering|May 15, 2012
Synthetic biology: an emerging engineering disciplineAllen A Cheng, Timothy K Lu
Current Opinion in Microbiology|August 27, 2011
The next generation of bacteriophage therapyTimothy K Lu, Michael S Koeris
Proceedings of the National Academy of Sciences of the United States of America|June 27, 2007
Dispersing biofilms with engineered enzymatic bacteriophageTimothy K Lu, James J Collins
Annual Review of Microbiology|July 15, 2020
Microbes as BiosensorsMaria Eugenia Inda, Timothy K Lu
Current Opinion in Chemical Biology|June 27, 2022
Engineering the human gut commensal Bacteroides thetaiotaomicron with synthetic biologyYong Lai, Naoki Hayashi, Timothy K Lu
ACS Synthetic Biology|March 22, 2022
Sense-and-Respond Payload Delivery Using a Novel Antigen-Inducible Promoter Improves Suboptimal CAR-T ActivationTingxi Guo, Dacheng Ma, Timothy K Lu
Pageof 16